These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 8990377

  • 1. Molecular executors of cell death--differential intrarenal expression of Fas ligand, Fas, granzyme B, and perforin during acute and/or chronic rejection of human renal allografts.
    Sharma VK, Bologa RM, Li B, Xu GP, Lagman M, Hiscock W, Mouradian J, Wang J, Serur D, Rao VK, Suthanthiran M.
    Transplantation; 1996 Dec 27; 62(12):1860-6. PubMed ID: 8990377
    [Abstract] [Full Text] [Related]

  • 2. Apoptosis is involved in acute cardiac allograft rejection in rats.
    Kageyama Y, Li XK, Suzuki S, Suzuki H, Suzuki K, Kazui T, Harada Y.
    Ann Thorac Surg; 1998 Jun 27; 65(6):1604-9. PubMed ID: 9647066
    [Abstract] [Full Text] [Related]

  • 3. Cytotoxic effector molecule gene expression in acute renal allograft rejection: correlation with clinical outcome; histopathology and function of the allograft.
    Nickel P, Lacha J, Ode-Hakim S, Sawitzki B, Babel N, Frei U, Volk HD, Reinke P.
    Transplantation; 2001 Sep 27; 72(6):1158-60. PubMed ID: 11579318
    [Abstract] [Full Text] [Related]

  • 4. Molecular analyses of human renal allografts: differential intragraft gene expression during rejection.
    Suthanthiran M.
    Kidney Int Suppl; 1997 Mar 27; 58():S15-21. PubMed ID: 9067937
    [Abstract] [Full Text] [Related]

  • 5. Perforin, Granzyme B, and fas ligand for molecular diagnosis of acute renal-allograft rejection: analyses on serial biopsies suggest methodological issues.
    Graziotto R, Del Prete D, Rigotti P, Anglani F, Baldan N, Furian L, Valente M, Antonello A, Marchini F, D'Angelo A, Gambaro G.
    Transplantation; 2006 Apr 27; 81(8):1125-32. PubMed ID: 16641597
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The granule exocytosis and Fas/FasLigand pathways at the time of transplantation and during borderline and acute rejection of human renal allografts.
    Carstens J, Markussen N, Madsen M.
    Transplant Proc; 2005 Oct 27; 37(8):3294-7. PubMed ID: 16298578
    [Abstract] [Full Text] [Related]

  • 8. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine.
    Li B, Hartono C, Ding R, Sharma VK, Ramaswamy R, Qian B, Serur D, Mouradian J, Schwartz JE, Suthanthiran M.
    N Engl J Med; 2001 Mar 29; 344(13):947-54. PubMed ID: 11274620
    [Abstract] [Full Text] [Related]

  • 9. Clinical application of molecular biology: a study of allograft rejection with polymerase chain reaction.
    Suthanthiran M.
    Am J Med Sci; 1997 May 29; 313(5):264-7. PubMed ID: 9145034
    [Abstract] [Full Text] [Related]

  • 10. Increased accuracy of renal allograft rejection diagnosis using combined perforin, granzyme B, and Fas ligand fine-needle aspiration immunocytology.
    Pascoe MD, Marshall SE, Welsh KI, Fulton LM, Hughes DA.
    Transplantation; 2000 Jun 27; 69(12):2547-53. PubMed ID: 10910275
    [Abstract] [Full Text] [Related]

  • 11. Serine proteinase inhibitor-9, an endogenous blocker of granzyme B/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts.
    Muthukumar T, Ding R, Dadhania D, Medeiros M, Li B, Sharma VK, Hartono C, Serur D, Seshan SV, Volk HD, Reinke P, Kapur S, Suthanthiran M.
    Transplantation; 2003 May 15; 75(9):1565-70. PubMed ID: 12792516
    [Abstract] [Full Text] [Related]

  • 12. Molecular diagnosis of renal-allograft rejection: correlation with histopathologic evaluation and antirejection-therapy resistance.
    Desvaux D, Schwarzinger M, Pastural M, Baron C, Abtahi M, Berrehar F, Lim A, Lang P, le Gouvello S.
    Transplantation; 2004 Sep 15; 78(5):647-53. PubMed ID: 15371663
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Apoptosis and expression of cytotoxic T lymphocyte effector molecules in renal allografts.
    Olive C, Cheung C, Falk MC.
    Transpl Immunol; 1999 Mar 15; 7(1):27-36. PubMed ID: 10375075
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intragraft activation of genes encoding cytotoxic T lymphocyte effector molecules precedes the histological evidence of rejection in human cardiac transplantation.
    Shulzhenko N, Morgun A, Zheng XX, Diniz RV, Almeida DR, Ma N, Strom TB, Gerbase-DeLima M.
    Transplantation; 2001 Nov 27; 72(10):1705-8. PubMed ID: 11726838
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Gene expression of perforin by peripheral blood lymphocytes as a marker of acute rejection.
    Shin GT, Kim SJ, Lee TS, Oh CK, Kim H.
    Nephron Clin Pract; 2005 Nov 27; 100(3):c63-70. PubMed ID: 15824509
    [Abstract] [Full Text] [Related]

  • 19. Intragraft mRNA cytotoxic molecule expression in renal allograft recipients.
    Carstens J, Ozbay A, Tørring C, Hansen HE.
    Transpl Immunol; 2009 Mar 27; 20(4):212-7. PubMed ID: 19141320
    [Abstract] [Full Text] [Related]

  • 20. Tim-3 expression in human kidney allografts.
    Ponciano VC, Renesto PG, Nogueira E, Rangel EB, Cenedeze MA, Franco MF, Câmara NO, Pacheco-Silva A.
    Transpl Immunol; 2007 Apr 27; 17(3):215-22. PubMed ID: 17331850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.